| 前收市價 | 11.20 |
| 開市 | 10.40 |
| 買盤 | 10.40 |
| 賣出價 | 10.80 |
| 拍板 | 40.00 |
| 到期日 | 2025-01-17 |
| 今日波幅 | 10.40 - 10.40 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 140 |
ZacksExact Sciences (EXAS) Witnesses Rising Expenses, Competition
Exact Sciences (EXAS) has numerous competitors, given the large market for colorectal cancer screening.
ZacksExact Sciences (EXAS) to Showcase Favorable Research Outcome
Exact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies that expand access to effective cancer screening and diagnostic tools for patients.
Insider MonkeyHedge Funds are Bullish on This Cancer Stock
We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we discuss why hedge funds have sizable positions in Exact Sciences Corporation (NASDAQ:EXAS). Challenges in the Health Sector The healthcare industry is considered to be a fairly defensive sector due to its need. According to a World […]
